Arizona Oncology Associates

Tucson, AZ

Accepting patients

Teclistamab

A Study of Outpatient Administration of Teclistamab, a BCMA-targeting Bispecific Antibody, in Multiple Myeloma Patients
Learn more
  • Bispecific Antibody
  • BCMA
  • Phase 2